GLP-1 drugs like Ozempic are associated with a higher risk of developing wet age-related macular degeneration in people with ...

A new study found a link between GLP-1s and a higher risk of neovascular age-related macular degeneration, an eye disease ...

Outlook Therapeutics, Inc. (Nasdaq: OTLK), today announced the Scottish Medicines Consortium (SMC) approval of LYTENAVA™ (bevacizumab gamma) for the treatment of wet age-related macular degeneration ...

NIH scientists explore a new multi-graft retinal surgery technique to advance cell therapy for treating dry age-related macular degeneration (AMD).

Metallic nanoparticles injected into the retina partly restored vision in blind mice and could work as a treatment for ...

About Wet AMD Wet age-related macular degeneration (wet AMD ... and best-in-class bioerodible Durasert E™ technology. Vorolanib brings a new mechanism of action to the treatment of VEGF-mediated ...

About Wet AMD Wet age-related macular degeneration (wet AMD ... Vorolanib brings a new mechanism of action to the treatment of VEGF-mediated retinal diseases as a potent and highly selective ...

In the last 20 years, there have been rapid advances in the treatment options ... patients with myopic macular degeneration complicated by CNV may benefit from a new ophthalmic frontier of ...

Since the approval of Luxturna, there has been a wave of gene therapies advancing in clinical trials to treat genetic vision ...

National Institutes of Health (NIH) scientists have developed a new surgical technique ... animals may help advance treatment options for dry age-related macular degeneration (AMD), which is ...